News
1 November, 2024 - 12:12 (CET)
Alerts
M
The Invitation to Manufacturers for HIV Infections and Related Diseases to submit an Expression of Interest for Product Evaluation to the WHO Prequalification Unit was recently updated.
The following products were added:
Lenacapavir, solution for subcutaneous injection, 463.5mg/1.5 ml (309mg/ml)
Lenacapavir, tablet, 300 mg
Emtricitabine/Tenofovir disoproxil fumarate/Levonorgestrel/Ethinylestradiol, tablet 200mg /300 mg/0.15 mg/0.03 mg